Literature DB >> 8807573

Coordinate regulation of PTH/PTHrP receptors by PTH and calcitriol in UMR 106-01 osteoblast-like cells.

E A González1, K J Martin.   

Abstract

High levels of PTH result in desensitization of target cells to further stimulation with PTH in vivo and in vitro. While studies in vitro demonstrate that the effect of PTH can be direct, it is also possible that studies in vivo may be complicated by the fact that other potential regulators of PTH action, such as increased levels of calcitriol, may play a role. Thus, we examined the actions of calcitriol and PTH on PTH/PTHrP-receptor expression in confluent cultures of UMR 106-01 osteoblast-like cells treated with calcitriol, PTH or both hormones for one to three days. Following these treatments, studies of PTH receptor binding, cAMP generation, and steady-state levels of PTH/PTHrP receptor mRNA were performed. Exposure to PTH resulted in a decrease in PTH stimulated cAMP generation by 88 +/- 2%, and PTH binding by 63 +/- 3%. Levels of PTH/PTHrP-receptor mRNA decreased progressively reaching 20% of control values after three days of PTH (100 nM) treatment. Calcitriol also resulted in a dose and time-dependent decrease in PTH/PTHrP-receptor mRNA, decreasing by 72 +/- 4% after 48 hours. PTH receptor binding and cAMP generation were diminished by 42 +/- 3% and 42 +/- 4%, respectively. Co-incubation of UMR 106-01 cells with submaximal doses of calcitriol and PTH together revealed that the levels of PTH/PTHrP-receptor mRNA were decreased by both hormones together to a greater extent than with either alone. These studies show that both calciotropic hormones, PTH and calcitriol, are potent regulators of PTH/PTHrP-receptor gene expression in UMR 106-01 osteoblast-like cells. Thus, stimulation of calcitriol production by PTH may result in a coordinated down-regulation of PTH receptor expression by these hormones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807573     DOI: 10.1038/ki.1996.287

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Regulation of PTH/PTH-related protein receptor expression by endogenous PTH-related protein in the rat osteosarcoma cell line ROS 17/2.8.

Authors:  P Du; P K Seitz; C W Cooper
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

2.  Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.

Authors:  Larry A Greenbaum; Ryszard Grenda; Ping Qiu; Irene Restaino; Amy Wojtak; Ana Paredes; Nadine Benador; Joel Z Melnick; Laura A Williams; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

Review 3.  New PTH assays and renal osteodystrophy.

Authors:  Isidro B Salusky; Harald Jüppner
Journal:  Pediatr Nephrol       Date:  2004-05-15       Impact factor: 3.714

4.  Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis.

Authors:  T Sugimoto; T Nakamura; Y Nakamura; Y Isogai; M Shiraki
Journal:  Osteoporos Int       Date:  2013-10-10       Impact factor: 4.507

5.  Bone responsiveness to parathyroid hormone is negatively associated with parathyroid hormone-lowering drug use in patients undergoing hemodialysis: a cross-sectional study.

Authors:  Naoto Tominaga; Tomoki Yonaha; Masayuki Yamanouchi; Hirofumi Sumi; Yasuhiro Taki; Yugo Shibagaki; Kazuhiro Shiizaki; Shozo Yano
Journal:  BMC Nephrol       Date:  2021-08-09       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.